United Press International Examines Vaccine Development for HIV/AIDS, Other Diseases
May 11, 2007
Researchers are "zeroing in on discovering" vaccines against HIV/AIDS and other diseases, such as malaria and tuberculosis, that largely affect the developing world, scientists said this week at the BIO International Convention in Boston, United Press International reports. According to UPI, advanced trials of HIV vaccines are underway in Africa and China. Seth Berkley, president of the International AIDS Vaccine Initiative, said that the vaccines are specific to the HIV strains found in the regions where the trials are taking place. Berkley added that clinical trials in India, Rwanda and Zambia have had "extraordinary enrollment rates."
Jerald Sadoff, president and CEO of the Aeras Global TB Vaccine Foundation, said that the group aims to bring the disease under control worldwide within 15 to 20 years. He added that the foundation plans to conduct final tests of a TB vaccine in South Africa and Southern India by 2008.
According to Loucq, efforts to develop vaccines for HIV, malaria and TB are being funded largely by not-for-profit foundations instead of the private sector. Loucq said that many pharmaceutical companies are reluctant to develop such vaccines because they tend to have small profit margins, adding, "It's viewed as a problem of no market." Not-for-profit foundations have raised hundreds of millions of dollars to develop vaccines against HIV, TB and malaria, UPI reports (Appel, United Press International, 5/9).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.